Compare KRT & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRT | SGP |
|---|---|---|
| Founded | 2000 | 2019 |
| Country | United States | United States |
| Employees | N/A | 65 |
| Industry | Plastic Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 773.2M | 650.9M |
| IPO Year | 2019 | N/A |
| Metric | KRT | SGP |
|---|---|---|
| Price | $41.10 | $20.72 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $26.50 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 118.7K | 109.3K |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | ★ 6.33% | N/A |
| EPS Growth | ★ 4.70 | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | ★ $467,743,000.00 | N/A |
| Revenue This Year | $13.05 | N/A |
| Revenue Next Year | $8.11 | N/A |
| P/E Ratio | $120.44 | ★ N/A |
| Revenue Growth | ★ 10.67 | N/A |
| 52 Week Low | $20.61 | $17.06 |
| 52 Week High | $41.38 | $30.56 |
| Indicator | KRT | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 87.21 | 51.66 |
| Support Level | $21.64 | $17.74 |
| Resistance Level | N/A | $22.86 |
| Average True Range (ATR) | 1.22 | 1.66 |
| MACD | 0.30 | 0.05 |
| Stochastic Oscillator | 100.00 | 39.13 |
Karat Packaging Inc is a distributor and manufacturer of disposable foodservice products and related items, including containers, bags, tableware, cups, lids, cutlery, straws, specialty beverage ingredients, gloves, and janitorial supplies, available in plastic, paper, biopolymer-based, and other compostable forms. The Company focuses on environmentally friendly products and provides customized solutions including product development, design, printing, and logistics services. It serves customers through chains and distributors, retail, and e-commerce/online, and operates in the manufacturing and distribution of single-use food and beverage products, as well as specialty food and beverage products and restaurant and warehouse supplies.
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.